Sarah Rudman
Papers
1
Total Citations
4
H-Index
1
About
Sarah Rudman is a pioneering urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for genitourinary cancers, with a particular focus on robotic-assisted retroperitoneal lymph node dissection (RPLND). Her major contribution lies in developing the "B-SAFE" approach, a structured framework for patient selection that optimizes outcomes in robotic RPLND, a technically demanding procedure for testicular cancer. This work, detailed in her 2025 paper, has garnered 4 citations in its early publication, signaling growing recognition among peers. Rudman’s research bridges surgical innovation and clinical decision-making, aiming to reduce morbidity while preserving oncologic efficacy. Her notable achievements include defining key anatomical and pathological parameters that guide surgeons in identifying ideal candidates for this robotic approach, thereby expanding access to less invasive treatment options. As a rising authority in urologic oncology, Rudman’s work is shaping the future of surgical care, offering students and researchers a model for integrating precision medicine with operative technique. Her ongoing contributions promise to further refine robotic surgery’s role in complex cancer management.
Research Focus
Key Achievements
Top Papers
- 1